{
    "id": "f4cdfc8d-fbc1-49bc-af9a-396cd0f24a84",
    "indications": "VALTOCOÂ® is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient's usual seizure pattern in patients with epilepsy 2 years of age and older.",
    "contraindications": "Administer VALTOCO by the nasal route only. ( 2.3 ) Dosage is dependent on the patient's age and weight. ( 2.2 ) Initial Dose: VALTOCO 5 mg and 10 mg doses are administered as a single spray intranasally into one nostril. Administration of 15 mg and 20 mg doses requires two nasal spray devices, one spray into each nostril. ( 2.2 ) Second Dose: A second dose, when required, may be administered at least 4 hours after the initial dose. If administered, use a new blister pack. ( 2.2 ) Maximum Dosage and Treatment Frequency: Do not use more than 2 doses to treat a single episode.  It is recommended that VALTOCO be used to treat no more than one episode every five days and no more than five episodes per month. ( 2.2 )",
    "adverseReactions": "VALTOCO nasal spray is contraindicated in patients with:\n                  \n                     Known hypersensitivity to diazepam \n                     Acute narrow angle glaucoma [see Warnings and Precautions (5.6)]",
    "ingredients": [
        {
            "name": "diazepam",
            "code": "Q3JTX2Q7TU"
        }
    ],
    "organization": "Neurelis, Inc",
    "name": "Valtoco",
    "effectiveTime": "20250506"
}